CORT CORCEPT THERAPEUTICS INC

Ownership history in MACQUARIE GROUP LTD  ·  18 quarters on record

This page tracks every 13F SEC filing in which MACQUARIE GROUP LTD reported a position in CORCEPT THERAPEUTICS INC (CORT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 47,706 +6,084 +14.6% 0.00% $4.0M $83.11
2025 Q2 ADDED 41,622 +40,476 +3531.9% 0.00% $3.1M $73.40
2022 Q3 REDUCED 1,146 -1,716 -60.0% 0.00% $73K $25.64
2022 Q2 UNCHANGED 2,862 0% 0.00% $68K $23.78
2022 Q1 UNCHANGED 2,862 0% 0.00% $64K $22.52
2021 Q4 UNCHANGED 2,862 0% 0.00% $57K $19.80
2021 Q3 UNCHANGED 2,862 0% 0.00% $56K $19.68
2021 Q2 UNCHANGED 2,862 0% 0.00% $63K $22.00
2021 Q1 REDUCED 2,862 -814 -22.1% 0.00% $68K $23.79
2020 Q4 UNCHANGED 3,676 0% 0.00% $96K $26.16
8 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CORT price (monthly, adj. close)
← Back to MACQUARIE GROUP LTD Holdings